Nirvana Life Sciences Inc's total assets for Q were C$211.76K, an increase of 242.37% from the previous quarter. TSE:NIRV total liabilities were C$1.03M for the fiscal quarter, a 12.80% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.